Recall of MiniMed 640G Insulin Infusion Pump (with software version 2.6)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Medtronic Australasia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2017-RN-00167-1
  • Event Risk Class
    Class I
  • Event Initiated Date
    2017-02-13
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    A software issue affecting some minimed 640g insulin infusion pumps that could prevent the internal battery from charging has been identified. should this issue occur, an alarm will be triggered and users will see a "power error detected" message accompanied by the number “25”, displayed on the pump screen. users are advised not to ignore this alarm and error message, which means that their pump has now stopped delivering insulin. if not, users could develop high blood sugar levels (hyperglycaemia).
  • Action
    Medtronic has contacted users who could potentially be affected and relevant health professionals to provide further information about this issue. Medtronic is advising users who experience this error to phone the Medtronic 24 hour Helpline (1800 777 808 - option 1). Users will be guided to troubleshoot to determine the cause of the error message and to perform a pump reset process which will reset the condition that caused the software anomaly. If the error cannot be corrected, the pump will be replaced. TGA will soon be publishing a web statement about this issue.

Device

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA